Viewing Study NCT06927466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-05-30 @ 1:16 AM
Study NCT ID: NCT06927466
Status: RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-04-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia View
Keywords: